Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches ...

Truist sets BioNTech's price target at $172, highlighting BNT327's revenue potential of $6B+ across multiple cancer indications. BioNTech's BNT327 could lead U.S. and European approvals for key ...

18.05.21 - Das Regierungspräsidium Gießen hatte bereits Mitte Januar den Umbau einer bestehenden Produktionsanlage der BioNTech Manufacturing Marburg GmbH für die zusätzliche Herstellung von ...

Dec 27 (Reuters) - BioNTech (22UAy.DE), opens new tab has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the ...

(RTTNews) - BioNTech SE (BNTX), Friday reached two separate settlements with the U.S. National Institutes of Health, and the University of Pennsylvania regarding the royalties payment of COVID-19 ...

BioNTech, which produced the first MRNA jab, has developed a "laboratory in a container", which could be shipped to several countries. Scientists and workers would then produce tens of millions of ...

https://www.tipranks.com/news/the-fly/alterity-ceo-says-filled-with-optimism-for-2025 Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last ...

Pfizer and BioNTech have started clinical trials of a new Covid vaccine which targets the Omicron variant. The companies plan to test the protection gained from the new vaccine as a booster jab ...

which centred on a manufacturing facility for mRNA vaccines, mainly targeting infectious diseases, along with R&D initiatives including clinical trials and funding for academic research. BioNTech ...